Send feedback

CEP290 p.Arg151Gln

c.452G>A · rs753374614 · VCV1011871

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
AlphaMissense
likely benign
0.167 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00256%, amr)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
3
Joubert syndrome

Computational evidence

Protein change
AlphaMissense0.167likely benign
REVEL0.166moderately benign-leaning
SaProtLLR -5.58tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 5.9GERP 2.1, phastCons 1
Regional constrainto/e 1.00unconstrained · MANE · 92 kb · p 0.89 · regional, not allelic
Overall
CADD27.6PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00256% Admixed American · 1/39,016 alleles
Filtering AF 0.000566% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000447%
Overall 0.00113% 17/1,500,650 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.00346% 28,923
Admixed Americangrpmax 0.00256% 39,016
African / African-American 0.00146% 68,368
South Asian 0.00138% 72,644
European (non-Finnish) 0.00106% 94,283

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CEP290
Protein
p.Arg151Gln
Coding
c.452G>A
MANE Select
NM_025114
dbSNP
rs753374614
Type
single nucleotide variant
Location
chr12:88131208 (GRCh38)
Gene constraint
LOEUF 1.094 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 60.90
Residue 151
the 'self-association (with itself or c-terminus)' region; a UniProt-annotated variant site (in lca10; also found in a patient with night blindness and hearing loss); the 'disordered' region
Full CEP290 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cep290-p-arg151gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown